SEARCH

SEARCH BY CITATION

References

  • 1
    Alessandrino EP,Della Porta MG,Bacigalupo A, et al. Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: A GITMO study. Haematologica 2010; 95: 476484.
  • 2
    Altes A,Remacha AF,Sureda A, et al. Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 987989.
  • 3
    Armand P,Kim HT,Cutler CS, et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 2007; 109: 45864588.
  • 4
    Kataoka K,Nannya Y,Hangaishi A, et al. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2009; 15: 195204.
  • 5
    Lee JW,Kang HJ,Kim EK,Kim H,Shin HY,Ahn HS. Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children. Bone Marrow Transplant 2009; 44: 793797.
  • 6
    Mahindra A,Bolwell B,Sobecks R, et al. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation. Br J Haematol 2009; 146: 310316.
  • 7
    Platzbecker U,Bornhauser M,Germing U, et al. Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS). Biol Blood Marrow Transplant 2008; 14: 12171225.
  • 8
    Pullarkat V,Blanchard S,Tegtmeier B, et al. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2008; 42: 799805.
  • 9
    Storey JA,Connor RF,Lewis ZT, et al. The transplant iron score as a predictor of stem cell transplant survival. J Hematol Oncol 2009; 2: 4452.
  • 10
    Kim YR,Kim JS,Cheong JW,Song JW,Min YH. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies. Acta Haematol 2008; 120: 182189.
  • 11
    Lim ZY,Fiaccadori V,Gandhi S, et al. Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation. Leuk Res 2009; 34: 723727.
  • 12
    Chow JK,Werner BG,Ruthazer R,Snydman DR. Increased serum iron levels and infectious complications after liver transplantation. Clin Infect Dis 2010; 51: e16e23.
  • 13
    Bazuave GN,Buser A,Gerull S,Tichelli A,Stern M. Prognostic impact of iron parameters in patients undergoing allo-SCT. Bone Marrow Transplant 2012; 47: 6064.
  • 14
    Sucak GT,Yegin ZA,Ozkurt ZN,Aki SZ,Yagci M. Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation. Transplant Proc 2010; 42: 18411848.
  • 15
    Kontoyiannis DP,Chamilos G,Lewis RE, et al. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer 2007; 110: 13031306.
  • 16
    Ozyilmaz E,Aydogdu M,Sucak G, et al. Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: The role of iron overload. Bone Marrow Transplant 2010; 45: 15281533.
  • 17
    Tachibana T,Tanaka M,Takasaki H, et al. Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies. Int J Hematol 2011; 93: 368374.
  • 18
    Morado M,Ojeda E,Garcia-Bustos J, et al. BMT: Serum ferritin as risk factor for veno-occlusive disease of the liver. Prospective Cohort Study. Hematology 2000; 4: 505512.
  • 19
    Maradei SC,Maiolino A,de Azevedo AM,Colares M,Bouzas LF,Nucci M. Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation. Blood 2009; 114: 12701275.
  • 20
    Lee SH,Yoo KH,Sung KW, et al. Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: Incidence, risk factors, and outcome. Bone Marrow Transplant 2010; 45: 12871293.
  • 21
    Armand P,Kim HT,Rhodes J, et al. Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation. Biol Blood Marrow Transplant 2011; 17: 852860.
  • 22
    Gray R. A class of K-sample tests for comparing the cumulative incidence of a competing risk. The annals of statistics. 1988; 16: 11401154.
  • 23
    Armand P,Kim HT,Zhang MJ, et al. Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: A Center for International Blood and Marrow Transplant Research Study. Biol Blood Marrow Transplant 2012; 18: 280288.
  • 24
    Armand P,Deeg HJ,Kim HT, et al. Multicenter validation study of a transplantation-specific cytogenetics grouping scheme for patients with myelodysplastic syndromes. Bone Marrow Transplant 2010; 45: 877885.
  • 25
    Artz AS,Wickrema A,Dinner S, et al. Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008; 14: 12091216.
  • 26
    Kanda J,Mizumoto C,Ichinohe T, et al. Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2011; 46: 208216.